The p15(INK4b)/p16(INK4a)/RB1 pathway is frequently deregulated in human pituitary adenomas

Akiyoshi Ogino1, Atsuo Yoshino, Yoichi Katayama

  • 1Department of Neurological Surgery, Nihon University School of Medicine, 30-1 Oyaguchi-Kamimachi, Itabashi-ku, Tokyo 173-8610, Japan. ayoshino@med.nihon-u.ac.jp

Insights

Pituitary adenoma growth may be driven by alterations in the RB1 pathway, with gene promoter hypermethylation being the most common cause. Most adenomas showed RB1 pathway deregulation, particularly p16(INK4a) gene hypermethylation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Pituitary adenomas are common brain tumors, but their development mechanisms are unclear.
  • The RB1 pathway is crucial for cell cycle regulation and tumor suppression.
  • Gene promoter hypermethylation is an emerging mechanism for silencing tumor suppressor genes.

Purpose of the Study:

  • To investigate RB1 pathway deregulation in sporadic pituitary adenomas.
  • To determine the frequency and patterns of gene promoter hypermethylation in these tumors.
  • To explore the role of RB1 pathway inactivation in pituitary tumorigenesis.

Main Methods:

  • Analysis of 42 sporadic human pituitary adenomas.
  • Methylation-specific polymerase chain reaction (PCR) assay to assess promoter methylation status of p15(INK4b), p16(INK4a), and RB1 genes.
  • Investigation of gene deletions and amplifications within the RB1 pathway.

Main Results:

  • The vast majority of pituitary adenomas (90.5%) exhibited alterations in the RB1 pathway.
  • Promoter hypermethylation was the predominant mechanism, affecting p15(INK4b) (35.7%), p16(INK4a) (71.4%), and RB1 (28.6%) genes.
  • Hypermethylation of p16(INK4a) was the most frequent deregulation observed.
  • RB1 and p16(INK4a) methylations were often mutually exclusive, but could co-occur with p15(INK4b) methylation.

Conclusions:

  • Inactivation of the RB1 pathway, primarily through promoter hypermethylation, plays a significant role in pituitary tumorigenesis.
  • p16(INK4a) gene hypermethylation is the most common alteration contributing to pituitary adenoma development.
  • The interplay between RB1, p16(INK4a), and p15(INK4b) methylation patterns provides insights into pituitary tumor formation.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.